Press Release - RQM+ Appoints Life Science Executive Margaret Keegan as New CEO

RQM+, the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry, today announced the appointment of Margaret Keegan as CEO. Keegan succeeds co-founder Maria Fagan, who is retiring and will join the board of directors as vice chair.


Keegan brings three decades of experience with executive roles at the largest life sciences service providers in the world, including PPD, IQVIA and, most recently, PRA Health Sciences where she was chief operating officer.


“It’s an incredibly exciting time to lead RQM+,” said Keegan. “By using innovative models that integrate best practices from across the life sciences spectrum, we have a tremendous opportunity to help our MedTech customers bring their products to market faster and keep them there. I look forward to applying my clinical and pharma experience to help RQM+ create solutions that leverage technology, expert knowledge and data insights. I am committed to continuing to make RQM+ the partner of choice for our customers and the destination of choice for world-leading MedTech talent. With our unrivaled collective knowledge and deep expertise, we help manufacturers overcome their unique challenges to ensure that patients continue to receive high-quality, life-improving treatments.”


Margaret recently served as the chair of CDISC, the global authority defining clinical data and interoperability standards for life sciences and healthcare, and continues to serve on its board.


Prior to RQM+, she served as chief operating officer of PRA Health Sciences (now ICON), one of the world’s largest public contract research organizations and pioneer of digital models in research. Prior to PRA Health Sciences, Keegan served as president of clinical development for IQVIA, the world’s largest healthcare data science company, where she was accountable for the delivery and growth of the clinical development business. At IQVIA, she also served as president of data safety, regulatory, biostatistics and data management. She is a mathematician and holds a bachelor’s degree in pure and applied mathematics from the University of Strathclyde and is also a chartered statistician.


About RQM+


RQM+ is the world’s leading provider of regulatory, clinical and quality solutions to the MedTech industry. We deliver transformative solutions to customers by providing unrivaled collective knowledge and expertise, fueled by our passion for customer success. Our experts are collaborative, laser-focused on customer needs, and committed to delivering high-value solutions for both medical devices and diagnostics that exceed expectations. For more information, visit rqmplus.com.


Media Contact: Lisa Casavant, +1.412.816.8102, lcasavant@rqmplus.com


Member Press Release - Life Science Group receives ISO 13485 accreditation

Life Science Group receives ISO 13485 accreditation. Life Science Group (LSG), one of the UK...

Read More >

Life Science Group transfers operations to new facility in Sandy, Bedfordshire

LSG has recently completed a move to new, larger facilities in Sandy, Bedfordshire. The facilities w...

Read More >

Improved Nucleic Acid Isolation

New QuickGene Range for DNA & RNA Extraction- Now with Automated Option

Read More >

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and c...

Read More >

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI Solutions (BBI) has announced the addition of over 80 new antibodies to its growing product port...

Read More >

New Multiplex Real-time PCR Kits Detect Clinically Relevant β-lactamase Genes

β-lactamase enzymes inactivate β-lactam antibiotics and render them ineffective for the treatment ...

Read More >